Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CorEvitas Inflammatory Bowel Disease (IBD) Registry

NCT03162549 is registered in ClinicalTrials.gov with CorEvitas as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03162549 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CorEvitas Inflammatory Bowel Disease (IBD) Registry
Lead sponsor
CorEvitas
Phase
Observational
Overall status
Enrolling by invitation
Start date
March 27, 2017
Completion date
December 31, 2100
Enrollment
2,287 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.